Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
Conclusion: Long-standing therapy with insulin glargine was associated with a lower odds of having any fractures compared to NPH insulin. Further studies are required to investigate whether the lower chance is due to a reduced frequency of hypoglycemia. Keywords: type 2 diabetes, fracture risk, insulin treatment, oral antidiabetic medication, primary care
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - Category: Endocrinology Tags: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Epidemiology | Health | Insulin | Internal Medicine | Lantus | Levemir | Metabolic Syndrome | Obesity | Primary Care | Primary Care Practices | Study